Supplementary Data 6 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation

Supplementary Data 6 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation

<p>Supplementary Data 6: Association between individual metabolites and radiation survival</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Priyanka Gopal (15050862) (author)
Diğer Yazarlar:	Brian D. Yard (15050865) (author), Aaron Petty (15050868) (author), Jessica C. Lal (15050871) (author), Titas K. Bera (15050874) (author), Trung Q. Hoang (15050877) (author), Alexandru D. Buhimschi (15050880) (author), Mohamed E. Abazeed (14936313) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Genetic biomarkers Computational Methods Algorithms Gene Technologies Mutation detection methods Lung Cancer
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Data 1 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
Yazar:: Priyanka Gopal (15050862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 2 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
Yazar:: Priyanka Gopal (15050862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 3 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
Yazar:: Priyanka Gopal (15050862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 4 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
Yazar:: Priyanka Gopal (15050862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 5 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
Yazar:: Priyanka Gopal (15050862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S6 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S7 from Gene Fusion Detection and Characterization in Long-Read Cancer Transcriptome Sequencing Data with FusionSeeker
Yazar:: Yu Chen (14962271)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S11 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S12 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S4 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S5 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S7 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S8 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S9 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Yazar:: Leon J. Wils (15055780)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Yazar:: Aleksandar Obradovic (7549517)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Yazar:: Aleksandar Obradovic (7549517)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study
Yazar:: Joel R. Eisner (15132120)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study
Yazar:: Joel R. Eisner (15132120)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study
Yazar:: Joel R. Eisner (15132120)
Baskı/Yayın Bilgisi: (2025)

Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
Yazar:: Subhamoy Chakraborty (16648124)
Baskı/Yayın Bilgisi: (2025)

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
Yazar:: Subhamoy Chakraborty (16648124)
Baskı/Yayın Bilgisi: (2025)

Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
Yazar:: Subhamoy Chakraborty (16648124)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
Yazar:: Subhamoy Chakraborty (16648124)
Baskı/Yayın Bilgisi: (2025)

Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Yazar:: Tobias Kessler (17079209)
Baskı/Yayın Bilgisi: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
Yazar:: Lavanya Sivapalan (15314248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables S1-S10 from <i>ACTA2</i> Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer
Yazar:: Sunho Park (15053897)
Baskı/Yayın Bilgisi: (2025)

Figure 1 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1-S3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Yazar:: Tobias Kessler (17079209)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Yazar:: Tobias Kessler (17079209)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S3 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Yazar:: Tobias Kessler (17079209)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Yazar:: Tobias Kessler (17079209)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_rh6hmn7fqlu9j0ctdh484a425o